ADGB

Across TCGA pan-cancer cohorts, ADGB mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ADGB data layer compared with 22 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher ADGB mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ADGB expression acts as an unfavorable survival marker, although some lineages such as PDAC and LSCC show a favorable association.

CCRCC, PDAC, and LSCC are the cancer types where ADGB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	II,III,IV	0.554	1.000	.025	7	view →
PDAC	OS	Tertile	IV	0.934	0.425	.024	6	view →
LSCC	DFS	Median	All	0.920	0.633	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

ADGB–CCRCC (OS)

Open the CCRCC breakdown →